Back to People Listing
Affiliate Faculty

Guido Ferrari

Assistant Professor, Surgery
School of Medicine
(919) 684-2862
gflmp@duke.edu
Visit Website
Guido Ferrari

Summary

Dr. Ferrari is currently an Associate Research Professor in the Department of Surgery, Division of Surgical Sciences at Duke University Medical Center. He is directing the ELISPOT, CTL, and ADCC laboratories for the HVTN central laboratory at Duke. He has been serving as a WHO/UNAIDS Vaccine Initiative consultant for the past six years, and coordinated the organization of 5 international workshops for the transfer of ELISpot and ICS technologies to new laboratory sites involved in HIV vaccine studies.

Topics

Locations

Projects

Recent Publications

Asbach, B, Kibler, KV, Köstler, J, Perdiguero, B, Yates, NL, Stanfield-Oakley, S, Tomaras, GD, Kao, S-F, Foulds, KE, Roederer, M, Seaman, MS, Montefiori, DC, Parks, R, Ferrari, G, Forthal, DN, Phogat, S, Tartaglia, J, Barnett, SW, Self, SG, Gottardo, R, Cristillo, AD, Weiss, DE, Galmin, L, Ding, S, Heeney, JL, Esteban, M, Jacobs, BL, Pantaleo, G, & Wagner, R. (2018, November 14). Priming with a potent HIV-1 DNA vaccine frames the quality of immune responses prior to a poxvirus and protein boost.
Kibler, KV, Asbach, B, Perdiguero, B, García-Arriaza, J, Yates, NL, Parks, R, Stanfield-Oakley, S, Ferrari, G, Montefiori, DC, Tomaras, GD, Roederer, M, Foulds, KE, Forthal, DN, Seaman, MS, Self, S, Gottardo, R, Phogat, S, Tartaglia, J, Barnett, S, Cristillo, AD, Weiss, D, Galmin, L, Ding, S, Heeney, JL, Esteban, M, Wagner, R, Pantaleo, G, & Jacobs, BL. (2018, November 14). Replication-competent NYVAC-KC yields improved immunogenicity to HIV-1 antigens in rhesus macaques, compared to non-replicating NYVAC. Journal of Virology,.
Shen, X, Moodie, Z, McMillan, A, Goodman, D, Yates, N, Spreng, R, Grunenberg, N, Gilbert, P, Phogat, S, Diazgranados, C, Laher, F, Bekker, L-G, Gray, G, Corey, L, McElrath, J, Ferrari, G, & Tomaras, G. (2018, October 1). V1V2 IgG and Antibody Fc Effector Functions in a Subtype C ALVAC-HIV and Bivalent Subtype C gp120/MF59 HIV-1 Vaccine Trial in South Africa. HIV Research for Prevention Meeting (HIVR4P) - AIDS Vaccine, Microbicide and ARV-Based Prevention Science. Madrid, SPAIN. MARY ANN LIEBERT, INC.
Msafiri, F, Joachim, A, Chissumba, RM, Geldmacher, C, Aboud, S, Stohr, W, Viegas, E, Kroidl, A, Munseri, PM, Wahren, B, Sandstrom, E, Robb, ML, McCormack, S, Joseph, S, Jani, I, Ferrari, G, Rao, M, Biberfeld, G, Lyamuya, E, & Nilsson, C. (2018, October 1). Frequent Anti-V1V2 Responses Induced by HIV-DNA Followed by HIV-MVA With or Without CN54rgp140/GLA-AF in Healthy Tanzanian and Mozambican Volunteers. HIV Research for Prevention Meeting (HIVR4P) - AIDS Vaccine, Microbicide and ARV-Based Prevention Science. Madrid, SPAIN. MARY ANN LIEBERT, INC.

View All Publications